Investors Push for Sale of Charles River Laboratories

Relational Investors and the California State Teachers’ Retirement System are pushing Charles River Laboratories to put itself up for sale, Reuters reported, citing an article in the Wall Street Journal. The two groups hold a 6.1% combined stake in that clinical research company. The Wall Street Journal reported that Charles River Laboratories – which has two main segments: preclinical services, and research models and services – could draw interest from private equity investors.

North AmericaUSBriefs